In the experiment, the researchers compared the PSA levels in the experimental samples (100 males asymptomatic for prostate disorders) with the data from two commercially available PSA tests conducted by a reference laboratory (Abbott and Elecsys by Roche). The gene discussed is KLK3; the disease is prostate disorder.